U.S. adults who felt the benefits of COVID-19 and MMR vaccines outweigh risks 2023

Published by
Preeti Vankar,
Nov 29, 2023
According to a survey from 2023, around 88 percent of U.S. adults stated they felt the benefits of childhood vaccines for measles, mumps and rubella (MMR) outweigh the risks. However, only 62 percent of adults felt the same about the COVID-19 vaccine. This statistic shows the percentage of U.S. adults who stated the benefits of childhood vaccines for measles, mumps and rubella (MMR) and COVID-19 outweigh the risks as of 2023.

Percentage of U.S. adults who stated the benefits of childhood vaccines for measles, mumps and rubella (MMR) and COVID-19 outweigh the risks as of 2023

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

May 2023

Region

United States

Survey time period

March 13 to 19, 2023

Number of respondents

10,701 respondents

Age group

18 years and older

Method of interview

Face-to-face interview, online survey

Supplementary notes

No information was provided about the remaining percentages to 100%.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Coronavirus (COVID-19): vaccines and vaccination campaign "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Coronavirus (COVID-19): vaccines and vaccination campaign

Pandemic situation

5

Search for vaccines

7

Leading products and companies

7

Vaccination campaign

5

Distribution inequality

5

Vaccination approval and willingness

8

Further Content: You might find this interesting as well

Topics

Coronavirus (COVID-19) vaccination in SpainCoronavirus disease (COVID-19) pandemicCoronavirus (COVID-19) in ItalyCoronavirus (COVID-19) in SpainCoronavirus (COVID-19) in Latin America
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu